Ignite Creation Date:
2024-05-06 @ 4:16 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04936867
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-13
First Post:
2021-06-16
Brief Title:
The CArdiac Imaging RegistrY Study
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Johann Wolfgang Goethe University Hospital
Study Overview
Official Title:
The CArdiac Imaging RegistrY Study Computed ToMogrAphy for Risk Stratification and Diagnostic Safety
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CARYSMA
Brief Summary:
In this prospective longitudinal observational investigator-led single centre cohort study we will include patients undergoing cardio-CT for clinical reasons to evaluate the role of cardio-CT terms of its diagnostic and prognostic value as well as risk-benefit ratio
Particular aims include
1 To determine the prevalence of CAD for age gender ethnicity relative to established risk models
2 To determine associations between CAD severity and plaque type and
1 with traditional risk factors arterial hypertension diabetes hypercholesterolemia smoking
2 blood markers of increased cardiovascular risk
3 To determine predictive associations of between CAD with outcome endpoint definitions in appendix
4 To determine the risk-benefit ratio number of subsequent interventions complications radiation exposure late onset of cancer diseases etc
Particular aims include
1 To determine the prevalence of CAD for age gender ethnicity relative to established risk models
2 To determine associations between CAD severity and plaque type and
1 with traditional risk factors arterial hypertension diabetes hypercholesterolemia smoking
2 blood markers of increased cardiovascular risk
3 To determine predictive associations of between CAD with outcome endpoint definitions in appendix
4 To determine the risk-benefit ratio number of subsequent interventions complications radiation exposure late onset of cancer diseases etc
Detailed Description:
Particular aims include
1 To determine the prevalence of CAD for age gender ethnicity relative to established risk models
2 To determine associations between CAD severity and plaque type and
1 with traditional risk factors arterial hypertension diabetes hypercholesterolemia smoking
2 blood markers of increased cardiovascular risk
3 To determine predictive associations of between CAD with outcome endpoint definitions in appendix
4 To determine the risk-benefit ratio number of subsequent interventions complications radiation exposure late onset of cancer diseases etc
1 To determine the prevalence of CAD for age gender ethnicity relative to established risk models
2 To determine associations between CAD severity and plaque type and
1 with traditional risk factors arterial hypertension diabetes hypercholesterolemia smoking
2 blood markers of increased cardiovascular risk
3 To determine predictive associations of between CAD with outcome endpoint definitions in appendix
4 To determine the risk-benefit ratio number of subsequent interventions complications radiation exposure late onset of cancer diseases etc
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None